Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record history now shows a new revision entry v3.6.5, indicating the page was updated to that revision.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a new revision entry, v3.6.4, in the record history, updating the page to a newer revision and replacing the previous v3.6.3. This reflects a metadata update to the page history rather than a change to the study data or user-facing content.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision tag v3.6.3 was added to the history, replacing the previous v3.6.2. This indicates a minor update to the page's underlying system or presentation rather than a change to trial data or content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page footer now shows a new site revision indicator, Revision: v3.6.2, replacing the previous Revision: v3.6.0.SummaryDifference0.1%

- Check75 days agoChange DetectedThe recruitment status indicates no longer looking for participants, signaling that enrollment is closed. The record version was updated to v3.6.0, with the prior v3.5.5 revision removed.SummaryDifference0.3%

- Check82 days agoChange DetectedThe header shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a new revision of the page history. This is a minor UI/version-tracking update to the study record history rather than a change to study data or content.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.